Thirona obtains EU MDR approval for AI eye screening software
Dutch medtech firm Thirona has been granted Class II CE certification under the EU Medical Devices Regulation (MDR) for its eye disease screening software.
The solution RetCAD uses artificial intelligence (AI) to analyse colour fundus images, showing the interior surface of the eye, for the presence of age-related macular degeneration...
Nijmegen-based AI software company, Thirona has developed an AI algorithm to detect and quantify lung abnormalities related to cystic fibrosis (CF).
PRAGMA-AI aims to process faster and automated analysis of CT scans of patients with the condition, delivering an assessment in several seconds.
WHY IT MATTERS
CF is a rare genetic disorder with approximately 70,000 known cases worldwide,...
Dutch AI medical image analysis company, Thirona has obtained a license on a patent for the treatment of Cystic Fibrosis (CF).
The patent allows Thirona to develop an AI algorithm that will analyse CT scans to identify abnormalities in the lungs, ensuring that they are identified from an early age and that a personalised treatment plan can follow.
WHY IT MATTERS
Worldwide, there are approximately...
